Calton & Associates Inc. Has $418,000 Holdings in UnitedHealth Group Inc (NYSE:UNH)
Calton & Associates Inc. cut its stake in UnitedHealth Group Inc (NYSE:UNH) by 48.3% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 1,690 shares of the healthcare conglomerate’s stock after selling 1,580 shares during the period. Calton & Associates Inc.’s holdings in UnitedHealth Group were worth $418,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors also recently modified their holdings of UNH. Crewe Advisors LLC bought a new stake in UnitedHealth Group during the fourth quarter worth $25,000. Pearl River Capital LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at $35,000. Canton Hathaway LLC bought a new position in shares of UnitedHealth Group in the 1st quarter valued at $36,000. Laurel Wealth Advisors LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at $42,000. Finally, Truvestments Capital LLC bought a new position in shares of UnitedHealth Group in the 1st quarter valued at $42,000. 85.74% of the stock is currently owned by hedge funds and other institutional investors.
A number of research analysts have recently commented on the company. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, February 27th. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, March 19th. Citigroup upgraded UnitedHealth Group from a “neutral” rating to a “buy” rating and increased their price target for the company from $247.00 to $280.00 in a research note on Friday, May 10th. UBS Group assumed coverage on UnitedHealth Group in a research note on Tuesday, April 23rd. They issued a “neutral” rating and a $238.00 price target for the company. Finally, SunTrust Banks dropped their price target on UnitedHealth Group to $300.00 and set a “buy” rating for the company in a research note on Wednesday, April 17th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $290.84.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.60 by $0.13. The company had revenue of $60.30 billion during the quarter, compared to the consensus estimate of $59.72 billion. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. The firm’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period last year, the business posted $3.04 EPS. On average, sell-side analysts forecast that UnitedHealth Group Inc will post 14.71 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th will be paid a $1.08 dividend. The ex-dividend date of this dividend is Friday, June 14th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $0.90. This represents a $4.32 annualized dividend and a dividend yield of 1.76%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 27.95%.
In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $239.02, for a total transaction of $1,195,100.00. Following the completion of the transaction, the director now owns 77,993 shares in the company, valued at approximately $18,641,886.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 29th. The shares were sold at an average price of $241.99, for a total value of $2,419,900.00. Following the transaction, the director now owns 187,663 shares of the company’s stock, valued at approximately $45,412,569.37. The disclosure for this sale can be found here. Insiders have sold a total of 32,930 shares of company stock valued at $7,941,533 in the last quarter. Company insiders own 0.82% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Calton & Associates Inc. Has $418,000 Holdings in UnitedHealth Group Inc (NYSE:UNH)” was published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.watchlistnews.com/calton-associates-inc-has-418000-holdings-in-unitedhealth-group-inc-nyseunh/3038987.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.